Cargando…

Regulatory T Cell Metabolism in Atherosclerosis

Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall...

Descripción completa

Detalles Bibliográficos
Autores principales: Baardman, Jeroen, Lutgens, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408402/
https://www.ncbi.nlm.nih.gov/pubmed/32650487
http://dx.doi.org/10.3390/metabo10070279
_version_ 1783567824081387520
author Baardman, Jeroen
Lutgens, Esther
author_facet Baardman, Jeroen
Lutgens, Esther
author_sort Baardman, Jeroen
collection PubMed
description Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall and the leading cause of cardiovascular disease. Therefore, therapeutic strategies to improve Treg number or function could be beneficial to preventing atherosclerotic disease development. A growing body of evidence shows that intracellular metabolism of Tregs is a key regulator of their proliferation, suppressive function, and stability. Here we evaluate the role of Tregs in atherosclerosis, their metabolic regulation, and the links between their metabolism and atherosclerosis.
format Online
Article
Text
id pubmed-7408402
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74084022020-08-13 Regulatory T Cell Metabolism in Atherosclerosis Baardman, Jeroen Lutgens, Esther Metabolites Review Regulatory T cells (Tregs) are capable of suppressing excessive immune responses to prevent autoimmunity and chronic inflammation. Decreased numbers of Tregs and impaired suppressive function are associated with the progression of atherosclerosis, a chronic inflammatory disease of the arterial wall and the leading cause of cardiovascular disease. Therefore, therapeutic strategies to improve Treg number or function could be beneficial to preventing atherosclerotic disease development. A growing body of evidence shows that intracellular metabolism of Tregs is a key regulator of their proliferation, suppressive function, and stability. Here we evaluate the role of Tregs in atherosclerosis, their metabolic regulation, and the links between their metabolism and atherosclerosis. MDPI 2020-07-08 /pmc/articles/PMC7408402/ /pubmed/32650487 http://dx.doi.org/10.3390/metabo10070279 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Baardman, Jeroen
Lutgens, Esther
Regulatory T Cell Metabolism in Atherosclerosis
title Regulatory T Cell Metabolism in Atherosclerosis
title_full Regulatory T Cell Metabolism in Atherosclerosis
title_fullStr Regulatory T Cell Metabolism in Atherosclerosis
title_full_unstemmed Regulatory T Cell Metabolism in Atherosclerosis
title_short Regulatory T Cell Metabolism in Atherosclerosis
title_sort regulatory t cell metabolism in atherosclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408402/
https://www.ncbi.nlm.nih.gov/pubmed/32650487
http://dx.doi.org/10.3390/metabo10070279
work_keys_str_mv AT baardmanjeroen regulatorytcellmetabolisminatherosclerosis
AT lutgensesther regulatorytcellmetabolisminatherosclerosis